ClinicalTrials.gg
RecruitingNCT06166355EOAN-VR-ABMUpdated May 8, 2026

Improving the Treatment of Anorexia Nervosa in Children Through Virtual Reality Body Exposure

An interventional study of Attentional Bias Modification Training and VR-based body exposure in Anorexia Nervosa, sponsored by University of Barcelona. Recruiting at 1 site in Spain. Open to participants aged Up to 14 Years. Per ClinicalTrials.gov, last updated 2026-05-08.

Sponsored by University of Barcelona · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jul 2024; still recruiting 2 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
108
Allocation
Randomized
Ages
Up to 14 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 15 studies in Anorexia Nervosa with a site in Spain — 4 open to participants now, 5 under way, none of them phase 3. Anorexia Nervosa · Spain.

Planned enrollment
2nd of 13
108 · median 44
Started
2024
the only one that year
No phase
11 of 15
3 open now
Registered
12th of 15
by date
Lead sponsor
4 of 15
University of Barcelona

Among the 15 studies in Anorexia Nervosa with a site in Spain, this one is the 2nd largest by planned enrollment of the 13 interventional ones that give a count, is the only one that started in 2024, is one of 11 with no phase, and was the 12th registered.

Anorexia Nervosa

471 studies on the registry are indexed under Anorexia Nervosa; 127 are open to participants now.

Browse Anorexia Nervosa studies →

Open to participants now

4 of the 15 studies in Anorexia Nervosa with a site in Spain are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 82 Anorexia Nervosa studies recruiting now, 18 (22%) set no upper age limit and 60 (73%) stop at 75 or younger; 48 take children under 18; 26 take healthy volunteers.

This study: Up to 14 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Anorexia Nervosa with a site in Spain, or all of them as a file.
02

Study summary

The age of onset of anorexia nervosa has been progressively decreasing in recent years. Also, the prevalence rates of childhood anorexia in many countries have grown significantly. This increase was already observed before the COVID-19 pandemic, but the confinements and the stress derived from them have caused this increase to accelerate. As in adolescent and adult patients, in childhood anorexia some of the core signs and symptoms are an extreme fear of gaining weight and avoidance of food. The consequences of the early-onset of anorexia can be very important since the maturation of the organism is more incomplete in children than in adolescents. Weight loss can have very severe consequences, since in children the percentage of body fat is lower. On the other hand, hormonal disorders derived from food deprivation also have very severe consequences for the development of different organs. General physical development and growth can be affected, with consequences such as not being able to reach normal height. The research carried out to date on the efficacy of treatments for childhood anorexia is very scarce. There are no specific treatment strategies or settings for children with anorexia, and little research has been done to tailor treatment for younger patients. Given the need to explore new treatments for anorexia nervosa specifically aimed at children, the objective of this project is to develop a program to carry out exposure to one's own body through virtual reality, gradually, with progressive increases in size until achieving a healthy weight. In the virtual exposure, patients will observe the image of an avatar in a mirror for the time necessary in each session to produce the reduction of the anxiety response. The avatars that will be developed for this purpose will have a physical constitution corresponding to children under 14 years of age, and physical proportions equivalent to those of each patient. The positive results obtained with a previous version of this treatment originally developed for adolescents and adults suggest that its adaptation to children can open new ways for exploring effective treatments for childhood anorexia.

Read the detailed description

The age of onset of anorexia nervosa (AN) has been progressively decreasing in recent years, and the prevalence of childhood AN has grown significantly. This increase was already observed before the COVID-19 pandemic, but the confinements have caused this increase to accelerate. The incidence of eating disorders (ED) was 15.3% higher in 2020 compared with previous years. The relative risk increased steadily from March 2020 onwards, exceeding 1.5 by the end of the year. The increase was primarily related to teenagers and AN. A higher proportion of patients in 2020 had suicidal ideation or attempted suicide. Although the diagnostic criteria of AN are applied equally regardless of age, there are differential characteristics between child patients and adolescents or adults in the form of presentation, epidemiology, comorbidity and, also, in outcomes. In most studies, an age of less than 14 has been used as a criterion to define the childhood presentation of this disorder, since it coincides with the legal criterion in many countries. The somatic and mental consequences of early-onset anorexia have a strong negative effect on later adult life. Regardless of the treatment applied, only about half of patients maintain their restored weight in the long term. Little research has been done to tailor treatment for younger patients. Therefore, there is an urgent need for studies on new strategies to treat this serious disorder in children. The objective of this project is to develop a program to carry out exposure to one's own body through virtual reality, with progressive increases in the body mass index (BMI). Patients will observe an avatar in a mirror for the time necessary in each session to produce habituation, extinguishing the anxiety response. The avatars will have a physical constitution corresponding to children under 14 years old, and physical proportions equivalent to those of each patient. The results obtained with the version of this treatment originally developed for adolescents and adults by the investigation group suggest that its adaptation to children can open new ways for exploring effective treatments for children AN. It will also be analyzed whether the addition of a component aimed at modifying attentional biases towards the body increases the efficacy of the exposure. The hypothesis is: if a component of virtual-reality body exposure is added to the usual treatment for AN in children, then the treatment will be more effective. Furthermore, if a component designed to reduce body attention bias is also added, then the efficacy of the treatment will be even greater. The efficacy of this treatment, aimed at reducing the fear of gaining weight, will be analyzed in a randomized controlled study in which a group of patients under 14 years of age will receive treatment as usual, another group will receive treatment as usual plus five booster sessions of virtual body exposure, and a third group will receive treatment as usual, plus five booster sessions of virtual body exposure plus modification of attentional biases towards the body.

03

Conditions studied

  • Anorexia Nervosa

Browse trials for

Keywords

  • Attentional Bias
  • Virtual Reality
  • Eye-Tracking
  • Body exposure procedure
  • Attentional bias modification training
04

Who can participate

Ages eligible
Up to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with a primary diagnosis of anorexia nervosa ()
  • Patients below 14 years old
  • Patients with \<18.5
  • Subsyndromal patients will also be included

Exclusion criteria

Exclusion Criteria:

  • Visual deficits
  • Epilepsy or neuroleptic medication
  • Psychotic disorder
  • Bipolar disorder
  • Medical complications
  • Pregnancy
  • Clinical cardiac arrhythmia
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
108 participants (estimated)

Study arms

  • Experimental
    Cognitive-behavioral therapy plus VR-based body exposure and Attentional Bias Modification Training.

    In this group, five sessions of VRE will be added to the usual CBT, as in the other experimental group, but, in addition, at the beginning of each of the exposure sessions, the training aimed at reducing the attentional bias will be carried out. The training will be developed through the visual selection of geometric figures that fit approximately with specific parts of the body. Each of these figures can have different colors. Specifically, the patient must detect and identify the figures that will appear in different parts of the avatar's body. In half of the trials, the shape of the figure must be discriminated and in the remaining 50%, the discrimination will be based on color. Throughout the training, the geometric figures will appear on weight-related body parts in 45% of the trials, and in another 45% of the trials, it will appear on non-weight-related body parts. In the remaining trials (10%), the test will appear on one of three neutral stimuli located next to the avatar.

    Behavioral: Attentional Bias Modification Training · Behavioral: VR-based body exposure · Behavioral: Cognitive-behavioral therapy

  • Experimental
    Cognitive-behavioral therapy for anorexia and VR-based body exposure:

    Patients assigned to this group will receive the usual CBT from the clinical unit or the hospital where they are, and additionally, five sessions of VR-based body exposure intervention. In these weekly sessions patients will go through a body exposure intervention in which they will own a virtual avatar with their real measurements, that will progressively increase its BMI values throughout the following exposure sessions until a healthy BMI value is reached.

    Behavioral: VR-based body exposure · Behavioral: Cognitive-behavioral therapy

  • Active comparator
    Cognitive behavioral therapy

    Patients assigned to this group will receive the usual treatment from the center in which they are recruited for the study (CBT), and will have to complete the evaluations following the same schedule as the experimental group.

    Behavioral: Cognitive-behavioral therapy

Interventions

  • BehavioralAttentional Bias Modification Training

    Combine usual cognitive-behavioral treatment (CBT) sessions with additional five VR-based body-exposure therapy sessions and five sessions of Attentional Bias Modification Training.

  • BehavioralVR-based body exposure

    Combine usual cognitive-behavioral treatment (CBT) sessions with additional five VR-based body-exposure therapy sessions

  • BehavioralCognitive-behavioral therapy

    Usual cognitive-behavioral treatment (CBT) sessions.

06

What researchers measure

Primary outcomes

  1. Change in Eating Disorder symptomatology: Eating Disorders Inventory-3 (EDI-3; Garner, 2004) drive for thinness (EDI-DT) scale

    Evaluation of the change in drive for thinness, with maximum possible score of 28, where higher scores indicate higher drive for thinness.

    Time frame: From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up

  2. Change in Eating Disorder symptomatology: Eating Disorders Inventory-3 (EDI-3; Garner, 2004) body dissatisfaction (EDI-BD) scale

    Evaluation of the change in body dissatisfaction, with maximum possible score of 40, where higher scores indicate higher body dissatisfaction.

    Time frame: From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up

  3. Change in body mass index values

    Evaluation of change in Body Mass Index values

    Time frame: From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up

Secondary outcomes

  1. Change in Body Anxiety: Physical Appearance State Anxiety Scale (PASTAS)

    Evaluation of body-related anxiety using the PASTAS, with a maximum score of 32, with higher scores indicating higher body-related anxiety

    Time frame: From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up

  2. Change in Body image disturbance: Body Appreciation Scale (BAS)

    Evaluation of the change in body appreciation using the BAS, with a scale of possible scores ranging from 13-65, where higher scores indicate higher body appreciation

    Time frame: From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up

  3. Change in Body image disturbance: Figural Drawing Scale for Body Image Assessment (BIAS-BD) body distortion scores

    Evaluation of the change in body distortion using the BIAS-BD body distortion scores, ranging from -80 to 80, with higher scores indicating higher body distortion

    Time frame: From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up

  4. Change in Body image disturbance: Figural Drawing Scale for Body Image Assessment (BIAS-BD) body dissatisfaction scores

    Evaluation of the change in body dissatisfaction using the BIAS-BD body dissatisfaction scores, ranging from -80 to 80, with higher scores indicating higher body dissatisfaction

    Time frame: From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up

  5. Change in complete fixation time of the gaze towards weight-related body parts

    Evaluation of the attentional bias towards the body using complete fixation time (evaluated in milliseconds) of the gaze towards weight-related body parts, with higher values indicating a greater attentional bias.

    Time frame: From pre-assessment to post-assessment after 6 weeks

  6. Change in number of fixations of the gaze towards weight-related body parts

    Evaluation of the attentional bias towards the body using number of fixations of the gaze towards weight-related body parts, with higher values indicating a greater attentional bias

    Time frame: From pre-assessment to post-assessment after 6 weeks

Other outcomes

  1. Body-related anxiety

    Visual analogue scale from 0 to 100, with higher scores indicating higher body-related anxiety

    Time frame: Up to 40 minutes. Baseline (prior to beginning the body exposure session), every two minutes during the exposure, and at the end of the body exposure session

  2. Fear of gaining weight

    Visual analogue scale from 0 to 100, with higher scores indicating higher fear of gaining weight

    Time frame: Up to 40 minutes. Baseline (prior to beginning the body exposure session) and at the end of the body exposure session

  3. Full body ownership illusion

    Visual analogue scale from 0 to 100, with higher scores indicating higher full body ownership illusion

    Time frame: Up to 40 minutes. Baseline (prior to beginning the body exposure session) and at the end of the body exposure session

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) underlying the results reported in this study, including demographic characteristics, clinical variables, and outcome measures, will be shared.

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: Data will be available beginning 6 months after publication of the results and will remain available for 3 years.

Access criteria: De-identified individual participant data underlying the results reported in this study will be available to researchers who provide a methodologically sound proposal. Requests should be submitted to the corresponding author. Access will be granted following institutional review and approval, and a data use agreement may be required. Data will be shared securely via electronic transfer.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2024 (actual). Primary completion is estimated for Dec 2026, 29 months after the start.

Of 149 non-industry interventional studies with no phase under Anorexia Nervosa, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 63. This study's planned 29 months is below that.

Counting every sponsor, half of 149 studies reached it within 43 months; a quarter within 24 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 4, 2023
First posted
Dec 12, 2023
StartActual
Jul 1, 2024
Primary completionEst.
Dec 30, 2026
CompletionEst.
Dec 30, 2026
Last update
May 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06166355
Collaborators
Hospital Sant Joan de Deu
Responsible party
Jose Gutierrez Maldonado (Professor, University of Barcelona) — Principal investigator
First posted
Dec 12, 2023
Start date
Jul 1, 2024
Primary completion
Dec 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
May 8, 2026

Study contacts

José Gutiérrez-Maldonado
Contact
jgutierrezm@ub.edu
93 312 51 24 ext. +34
Marta Ferrer-Garcia
Contact
martaferrerg@ub.edu
667287894 ext. +34
José Gutiérrez-Maldonado
principal investigator · University of Barcelona

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion